ID: ALA4248673

Max Phase: Preclinical

Molecular Formula: C27H44O5

Molecular Weight: 448.64

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)CCC[C@](C)([C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]2[C@@](C)(CCC(=O)O)CC(=O)C[C@]23C)O1

Standard InChI:  InChI=1S/C27H44O5/c1-23(2)10-7-11-27(6,32-23)18-8-13-25(4)22(18)19(29)14-20-24(3,12-9-21(30)31)15-17(28)16-26(20,25)5/h18-20,22,29H,7-16H2,1-6H3,(H,30,31)/t18-,19+,20+,22-,24-,25+,26+,27+/m0/s1

Standard InChI Key:  BPOCXSHOKZMVTQ-WKFGEGFWSA-N

Associated Targets(Human)

Sodium/potassium-transporting ATPase 386 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 448.64Molecular Weight (Monoisotopic): 448.3189AlogP: 5.38#Rotatable Bonds: 4
Polar Surface Area: 83.83Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.58CX Basic pKa: CX LogP: 3.95CX LogD: 1.21
Aromatic Rings: 0Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: 2.66

References

1. Wu Q, Chen P, Tu G, Li M, Pan B, Guo Y, Zhai J, Fu H..  (2018)  Synthesis and evaluation of panaxatriol derivatives as Na+, K+-ATPase inhibitors.,  28  (17): [PMID:30049579] [10.1016/j.bmcl.2018.07.027]

Source